LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth

Lifevantage NASDAQ: LFVN executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion.

President and CEO Terrence Moorehead, who recently joined the company, said LifeVantage differentiates itself from conventional supplement companies through products designed to support the body’s own processes rather than simply add ingredients. He highlighted the company’s Protandim product line, including Nrf2 for cellular defense, Nrf1 for cellular energy and an NAD product positioned around longevity.

Moorehead said the company needs to communicate the products’ benefits and clinical support more effectively. “We’re not maximizing the language behind it,” he said, adding that LifeVantage needs to improve its messaging, packaging, digital advertising and social-media presence.

Consumer Relevance and Product Positioning

Moorehead said the company sees opportunities to update product positioning and price points while protecting its historically high gross margins. He said certain products may require reformulation or repackaging to fit target price categories.

He also discussed the company’s MindBody GLP-1 System, which experienced substantial initial demand in fiscal 2025 before sales declined in fiscal 2026. Moorehead attributed the decline partly to a natural progression following product launch, with some customers continuing to use the product and others moving away from it. He also cited increasing competition, declining prices for GLP-1 products and new product formats entering the market.

According to Moorehead, LifeVantage did not respond quickly enough to competitive developments and did not generate sufficient new-customer acquisition to sustain the product’s earlier sales levels. He said management expects to focus over the next 12 months on improving MindBody’s pricing, positioning and customer access, potentially including greater use of digital and social-media channels.

Margin and Efficiency Initiatives

The company’s recent top-line deterioration over the past 12 to 18 months has reduced operating leverage, Moorehead said. He said the company is evaluating supply-chain initiatives, organizational structure, technology and automation to support profitability without relying solely on cost cuts.

“We’re not going to cut our way to success,” Moorehead said. “We’re going to grow our way to success.”

CFO Carl Aure said LifeVantage reduced selling, general and administrative expenses by nearly $10 million, or about 15%, despite a year-over-year revenue decline. However, he said the reductions were not sufficient to fully offset the impact of lower revenue.

Aure said the company is focused on restoring gross margin to above 80%, including through a review of logistics operations. He said LifeVantage is also looking for further SG&A savings through technology and operating efficiencies.

Moorehead said management wants a “smarter and more powerful organization,” including more frequent engagement with the company’s sales force through less costly technology-enabled formats. He also pointed to potential applications for automation and artificial intelligence.

Supply Chain and International Growth

LifeVantage uses an outsourced, asset-light manufacturing model. Aure said most international markets are supplied through U.S.-based third-party contract manufacturers, though the company sources certain products locally for Japan.

Moorehead said the company could explore local sourcing in markets such as Mexico, where consumers may be especially price sensitive. Local sourcing could potentially support lower costs, faster product launches and market registrations, he said.

While international markets account for about 20% of company revenue, Moorehead said LifeVantage’s immediate priority is strengthening its U.S. business. After that, management expects to focus on expanding within markets where it already operates, particularly Japan and Mexico.

Moorehead described Japan as a significant opportunity supported by an existing local team. He also said Mexico’s growing supplement market, increasing digital sophistication and broader payment options could support a “next generation” market-development approach. He added that success in Mexico could potentially help LifeVantage reach Hispanic consumers in the United States.

Capital Allocation

Moorehead and Aure said they do not believe LifeVantage’s past dividend and share-repurchase activity prevented the company from investing in growth. Moorehead said the company intends to continue its dividend and share-repurchase program while directing more capital toward digital capabilities, artificial intelligence, brand development and deeper penetration of existing markets.

Aure said the company’s business model has historically generated free cash flow beyond its operating needs, enabling investments in areas such as its compensation plan and product roadmap. Going forward, he said management expects to maintain a balanced capital-allocation approach while increasing investments in technology, digital initiatives and the brand.

About Lifevantage (NASDAQ:LFVN)

LifeVantage Corporation is a health and wellness company that develops, markets and sells dietary supplements, skincare products and other wellness offerings. Its products are designed to support areas such as cellular health, antioxidant defenses, healthy aging, beauty and overall well-being.

The company's product portfolio has included Protandim, a line of supplements centered on the body's antioxidant response, as well as LifeVantage skincare and wellness products. LifeVantage sells primarily through a direct-selling model that combines independent distributors, known as consultants, with digital and e-commerce channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets, including Canada, Japan, Australia, Mexico, Hong Kong and Taiwan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.